Ensign Group Inc(ENSG) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 10 at 7:30 PM ET (Korea 9/11 08:30)
Full metrics table
| Index | - | P/E | 27.07 | EPS (ttm) | 6.38 | Insider Own | 3.6% | Shs Outstand | 58.3M | Perf Week | 0.05% |
| Market Cap | 10.07B | Forward P/E | 20.2 | EPS next Y | 9.73% | Insider Trans | -0.16% | Shs Float | 56.2M | Perf Month | -4.11% |
| Enterprise Value | 12.00B | PEG | 1.61 | EPS next Q | 1.96 | Inst Own | 91.53% | Short Float | 2.68% | Perf Quarter | 13.94% |
| Income | 0.38B | P/S | 1.84 | EPS this Y | 18.63% | Inst Trans | -2.28% | Short Ratio | 2.23 | Perf Half Y | -17.89% |
| Sales | 5.49B | P/B | 4.12 | EPS next 5Y | 12.53% | ROA | 7.09% | Short Interest | 1.51M | Perf YTD | -0.81% |
| Book/sh | 41.9 | P/C | 31.39 | EPS past 3/5Y | 13.93% 13.84% | ROE | 16.98% | 52W High | -20.74% ($218.00) | Perf Year | 4% |
| Cash/sh | 5.5 | P/FCF | 24.03 | Sales past 3/5Y | 19.77% 16.5% | ROIC | 8.29% | 52W Low | 22.04% ($141.58) | Perf 3Y | 79.97% |
| Dividend Est. | $0.27 (0.16%) | EV/EBITDA | 20.12 | EPS Y/Y TTM | 15.48% | Gross Margin | 13.96% | Volatility(W/M) | 1.78% 2.11% | Perf 5Y | 115.77% |
| Dividend TTM | 0.26 | EV/Sales | 2.19 | Sales Y/Y TTM | 18.89% | Oper. Margin | 8.78% | ATR (14) | 3.95 | Perf 10Y | 798.68% |
| Dividend Ex-Date | 2026/6/30 | Quick Ratio | 1.21 | EPS Q/Q | 16.43% | Profit Margin | 6.9% | RSI (14) | 43.54 | Recom | 1.57 |
| Dividend Gr. 3/5Y | 4.35% 4.56% | Current Ratio | 1.21 | Sales Q/Q | 17.33% | SMA20 | -2.13% ($176.55) | Beta | 0.66 | Target Price | $220 |
| Payout | 4.32% | Debt/Eq | 0.92 | Earnings | 2026/7/27 | SMA50 | -1.27% ($175.01) | Rel Volume | 0.56 | Prev Close | $171.76 |
| Employees | 46000 | LT Debt/Eq | 0.87 | EPS/Sales Surpr. | 3.91% -0.08% | SMA200 | -5.18% ($182.23) | Avg Volume(3M) | 0.67M | Price | $172.79 |
| IPO | 2007/11/9 | Option/Short | Yes/Yes | Trades | 9157 | Volume | 379,264 | Change | 0.6% |
Company
ENSG is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A US healthcare company that operates skilled nursing facilities and rehabilitation and senior care facilities, making it a long-term and post-acute care provider whose performance is driven by aging-related demand and expansion through acquisitions.
Over the past 1 year, roughly in the middle
21% below its 1-year high.
ENSG makes money exceptionally well
8.78% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +18.6% this year.
Tap to view numbers
The price looks about right
Trading at 27.1 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +80.0% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 0.16% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 91.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
SCDV 0.07%
KNOW 0.04%
BOUT 0.04%
OSCV 0.03%
DBSC 0.02%It ranks #4 in the industry
Based on market cap of $10B.
ENSG $10B PER 27.1
HCA $91B PER 14.1
THC $21B PER 10.2
EHC $12B PER 19.7
FAQ
What kind of company is ENSG?
ENSG belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of ENSG?
The market cap of ENSG is approximately $10.1B, ranking 935 within its sector.
Does ENSG pay dividends?
ENSG has a dividend yield of approximately 0.16%, with an annual dividend of $0.27.
What is the P/E ratio of ENSG?
ENSG has a P/E ratio of approximately 27.1x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ENSG?
ENSG has recorded a 52-week high of $218.00 and a low of $141.58.
